Kei Industries (KEI.NS) traded down -3.82 % during a 24 hours period ending at 04:04 PM Central Europe on Monday 26th. One Kei Industries stock can currently be bought for about INR 3,899.5 on popular exchanges. Current supply of Kei Industries stocks is 95.6 mn. Kei Industries has a current market capitalization of INR 356.3 bn and approximately INR 3.1 bn worth of Kei Industries was traded on exchanges in the last 24 hours. Since last month end, Kei Industries has traded -19.66 % down. Simple moving average of last 200 days is at INR 4,844.66. The highest price of past 52 weeks was recorded at INR 5,899 on 08/18/2026. 52 weeks low was at INR 3,666.1 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
Authum Investment & Infrastr (AIIL.NS) traded down -3.69 % and now trades at INR 486.75. Authum Investment & Infrastr has a market capitalisation of INR 421.9 bn. Authum Investment & Infrastr has a current price to earnings ratio of 20.18.
Glaxosmithkline Pharmaceutic (GLAXO.NS) traded down -1.19 % and now trades at INR 2,445.9. Current market capitalisation for Glaxosmithkline Pharmaceutic is INR 407.4 bn. Current price/earnings ratio for Glaxosmithkline Pharmaceutic is 39.32.
Sterlite (STLTECH.NS) traded up 3.22 % and now trades at INR 867.55. Current market capitalisation for Sterlite is INR 421.5 bn. Sterlite has a current price to earnings ratio of 718.83. Sterlite Technologies reported a strong quarter ending 30 September 2026, with earnings per share rising markedly and revenue growing more than one‑and‑a‑half times compared to the same period a year earlier. The company’s order book expanded to over ₹35 trillion, largely driven by long‑term contracts with global hyperscalers and a focus on integrated data‑centre connectivity solutions. Revenue mix is shifting from standalone optical fibre cables to higher‑margin connectivity systems, contributing to a notable improvement in operating margins. Management highlighted a debt‑free balance sheet and planned capital investments to boost fibre and pre‑form capacity. Analysts noted that the company’s performance now reflects a broader demand surge for high‑density optical fibre driven by AI and data‑centre expansion, while cautioning that continued growth will depend on execution of the growing backlog.
Ajanta Pharma (AJANTPHARM.NS) traded up 0.41 % and now trades at INR 3,381. Current market capitalisation for Ajanta Pharma is INR 410.4 bn. Current price/earnings ratio for Ajanta Pharma is 38.85.
Balkrishna Industries (BALKRISIND.NS) traded down -0.02 % and now trades at INR 2,109.4. Balkrishna Industries has a market capitalisation of INR 407.9 bn. Current price/earnings ratio for Balkrishna Industries is 31.02.
